Kazumichi Abe Selected Research

triazulenone (loprazolam)

4/2019

Changes in serum levels of leucine-rich α2-glycoprotein predict prognosis in primary biliary cholangitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazumichi Abe Research Topics

Disease

19	Autoimmune Hepatitis 07/2022 - 07/2004
15	Liver Diseases (Liver Disease) 01/2020 - 03/2004
12	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2020 - 07/2004
11	Fibrosis (Cirrhosis) 01/2021 - 02/2010
9	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2004
9	Hepatitis 02/2019 - 07/2004
7	Neoplasms (Cancer) 12/2021 - 11/2004
6	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022 - 01/2012
6	Non-alcoholic Fatty Liver Disease 10/2020 - 01/2017
5	Inflammation (Inflammations) 06/2021 - 10/2007
5	Chronic Hepatitis C 03/2017 - 12/2002
4	Infections 12/2021 - 12/2017
4	Ascites 12/2021 - 02/2010
3	Colitis 09/2021 - 10/2007
3	Necrosis 06/2016 - 06/2005
3	Chemical and Drug Induced Liver Injury 06/2016 - 09/2014
2	Jaundice (Icterus) 02/2021 - 12/2020
2	Hepatic Encephalopathy 01/2021 - 11/2020
2	Varicose Veins (Varicose Vein) 11/2020 - 02/2010
2	Thrombosis (Thrombus) 11/2020 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 05/2019 - 09/2012
2	Anemia 01/2019 - 06/2016
2	Hyponatremia 09/2018 - 01/2015
2	Thrombocytopenia (Thrombopenia) 12/2017 - 06/2016
2	Disseminated Intravascular Coagulation 01/2015 - 02/2012
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2015 - 01/2006
2	Cholangitis 09/2014 - 01/2013
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2014 - 07/2004
1	Atrophy 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 02/2021
1	Abscess 01/2021
1	Hyperglycemia 01/2021
1	Abdominal Obesity 01/2021
1	Fatigue 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Overweight 01/2021
1	Obesity 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Adenocarcinoma of Lung 12/2020
1	Sclerosing Cholangitis 12/2020
1	Carcinoma (Carcinomatosis) 12/2020

Drug/Important Bio-Agent (IBA)

8	Immunoglobulin G (IgG)IBA 03/2021 - 09/2012
5	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020 - 09/2007
5	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2018
5	AntibodiesIBA 01/2017 - 05/2005
5	Proteins (Proteins, Gene)FDA Link 01/2015 - 07/2004
4	Methylprednisolone FDA LinkGeneric 12/2021 - 09/2008
4	Alanine Transaminase (SGPT)IBA 03/2021 - 07/2011
4	EnzymesIBA 03/2021 - 09/2014
4	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 02/2021 - 01/2011
4	Prednisolone (Predate)FDA LinkGeneric 02/2021 - 02/2010
4	AutoantibodiesIBA 09/2014 - 12/2007
3	AntigensIBA 12/2021 - 01/2008
3	SteroidsIBA 02/2021 - 02/2012
3	Alkaline PhosphataseIBA 12/2020 - 11/2010
3	Keratin-18 (Keratin 18)IBA 05/2020 - 09/2018
3	BilirubinIBA 01/2020 - 07/2011
3	Antiviral Agents (Antivirals)IBA 01/2020 - 12/2002
3	Pharmaceutical PreparationsIBA 04/2019 - 01/2013
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2019 - 07/2011
3	Immunoglobulin M (IgM)IBA 01/2017 - 01/2013
3	Antinuclear AntibodiesIBA 06/2016 - 09/2007
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 07/2022 - 09/2013
2	Complement C1q (C1q Complement)IBA 09/2021 - 06/2021
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 06/2021 - 10/2007
2	Dextrans (Dextran)FDA Link 06/2021 - 10/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 09/2019
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2021 - 07/2020
2	Antithrombin IIIIBA 11/2020 - 01/2016
2	danaparoid (Orgaran)FDA Link 11/2020 - 01/2016
2	SodiumIBA 09/2020 - 09/2018
2	CytokinesIBA 01/2020 - 06/2005
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 02/2012
2	InterferonsIBA 03/2017 - 01/2009
2	GlobulinsIBA 04/2014 - 07/2011
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2012 - 01/2008
2	Vitamin K FDA Link 01/2012 - 01/2008
2	acarboxyprothrombin (PIVKA)IBA 01/2012 - 01/2008
2	GlucocorticoidsIBA 11/2011 - 07/2004
2	Interferon-betaIBA 09/2008 - 12/2002
2	Tumor Biomarkers (Tumor Markers)IBA 01/2008 - 11/2004
1	Guanosine Triphosphate (GTP)IBA 07/2022
1	Complement Factor H (Factor H)IBA 07/2022
1	Complement System Proteins (Complement)IBA 07/2022
1	lenvatinibIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 12/2021
1	CateninsIBA 06/2021
1	pazopanib FDA Link 02/2021
1	ThioredoxinsIBA 01/2021
1	IsoflavonesIBA 01/2021
1	EquolIBA 01/2021
1	pembrolizumabIBA 12/2020
1	Immune Checkpoint InhibitorsIBA 12/2020

Therapy/Procedure

18	Therapeutics 12/2021 - 12/2002
6	Drug Therapy (Chemotherapy) 12/2020 - 11/2009
5	Aftercare (After-Treatment) 01/2021 - 04/2018
2	Exercise Therapy (Therapy, Exercise) 05/2020 - 01/2017
2	Renal Dialysis (Hemodialysis) 07/2019 - 01/2019
2	Liver Transplantation 01/2012 - 01/2006
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 11/2020